id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-290750-85731og8	Danese, Silvio	Management of IBD during the COVID-19 outbreak: resetting clinical priorities	2020-03-25		.txt	text/plain	1798	86	49	Because of the very high transmission capacity, the WHO declared the outbreak of coronavirus disease (COVID-19) caused by SARS-CoV-2 infection a public health emergency of international concern. Additional recommendations for patients with IBD from the IOIBD: • Medicines such as mesalamine are safe • If possible, withdraw from steroid use • Biologic agents used to treat IBD (e.g. anti-TNF agents, ustekinumab and vedolizumab) are generally safe; there are no recommendations to stop taking these medications and the effects of these drugs are present for many months • Thiopurines and tofacitinib tend to inhibit the immune response to viral infections, but stopping these agents in the short-term will not help • Get the influenza vaccination • Stay at home and minimize social contact c | Strategies to enable maintenance of our biologic agent clinic during the COVID-19 outbreak in Italy include checkpoints at hospital entrances for symptom screening and use of surgical masks for clinical staff and patients.	./cache/cord-290750-85731og8.txt	./txt/cord-290750-85731og8.txt